Similar articles for PMID: 25937861

Year	Number of Results
1994	2
1995	1
1996	1
1998	4
1999	4
2000	6
2001	2
2002	4
2003	2
2004	1
2005	1
2006	4
2007	2
2009	3
2010	1
2011	5
2012	2
2013	2
2014	4
2015	11
2016	5
2017	3
2018	2
2020	3
2021	3
2023	1
2024	0

1

Hepatitis C virus genetic variability and evolution.

Echeverría N, Moratorio G, Cristina J, Moreno P. Echeverría N, et al. World J Hepatol. 2015 Apr 28;7(6):831-45. doi: 10.4254/wjh.v7.i6.831. World J Hepatol. 2015. PMID: 25937861 Free PMC article. Review.

2

The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control.

Bukh J. Bukh J. J Hepatol. 2016 Oct;65(1 Suppl):S2-S21. doi: 10.1016/j.jhep.2016.07.035. J Hepatol. 2016. PMID: 27641985 Review.

3

New insights into the HCV quasispecies and compartmentalization.

Farci P. Farci P. Semin Liver Dis. 2011 Nov;31(4):356-74. doi: 10.1055/s-0031-1297925. Epub 2011 Dec 21. Semin Liver Dis. 2011. PMID: 22189976 Review.

4

Pathogenesis, diagnosis and management of hepatitis C.

Boyer N, Marcellin P. Boyer N, et al. J Hepatol. 2000;32(1 Suppl):98-112. doi: 10.1016/s0168-8278(00)80419-5. J Hepatol. 2000. PMID: 10728798 Review.

5

T-cell therapy for chronic viral hepatitis.

Bertoletti A, Tan AT, Koh S. Bertoletti A, et al. Cytotherapy. 2017 Nov;19(11):1317-1324. doi: 10.1016/j.jcyt.2017.07.011. Epub 2017 Aug 25. Cytotherapy. 2017. PMID: 28847469 Review.

6

Deep sequencing and phylogenetic analysis of variants resistant to interferon-based protease inhibitor therapy in chronic hepatitis induced by genotype 1b hepatitis C virus.

Sato M, Maekawa S, Komatsu N, Tatsumi A, Miura M, Muraoka M, Suzuki Y, Amemiya F, Takano S, Fukasawa M, Nakayama Y, Yamaguchi T, Uetake T, Inoue T, Sato T, Sakamoto M, Yamashita A, Moriishi K, Enomoto N. Sato M, et al. J Virol. 2015 Jun;89(11):6105-16. doi: 10.1128/JVI.03127-14. Epub 2015 Mar 25. J Virol. 2015. PMID: 25810555 Free PMC article.

7

NIH Consensus Statement on Management of Hepatitis C: 2002.

[No authors listed] [No authors listed] NIH Consens State Sci Statements. 2002 Jun 10-12;19(3):1-46. NIH Consens State Sci Statements. 2002. PMID: 14768714 Free article. Review.

8

[Clinical impact of hepatitis C virus genomic variations].

Ergünay K, Abacıoğlu H. Ergünay K, et al. Mikrobiyol Bul. 2015 Oct;49(4):625-35. doi: 10.5578/mb.10245. Mikrobiyol Bul. 2015. PMID: 26649421 Free article. Review. Turkish.

9

Evolution of hepatitis C virus quasispecies during repeated treatment with the NS3/4A protease inhibitor telaprevir.

Susser S, Flinders M, Reesink HW, Zeuzem S, Lawyer G, Ghys A, Van Eygen V, Witek J, De Meyer S, Sarrazin C. Susser S, et al. Antimicrob Agents Chemother. 2015 May;59(5):2746-55. doi: 10.1128/AAC.04911-14. Epub 2015 Feb 23. Antimicrob Agents Chemother. 2015. PMID: 25712364 Free PMC article. Clinical Trial.

10

Dynamics of serum hepatitis C virus load and quasispecies complexity during antiviral therapy in patients with chronic hepatitis C.

Grahovac B, Bingulac-Popovic J, Vucelic B, Hrstic I, Ostojic R, Drazic V, Balija M, Grgicevic D. Grahovac B, et al. J Clin Virol. 2001 Jan;20(1-2):85-9. doi: 10.1016/s1386-6532(00)00160-8. J Clin Virol. 2001. PMID: 11163588

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

75 results

Results by year